NutriBand Terminates Subsidiary Sale Due to Buyer's Payment Default

summarizeSummary

NutriBand Inc. announced the immediate termination of its agreement to sell subsidiary Pocono Pharmaceuticals, Inc., citing the buyer's failure to pay required late fees.

check_boxKey Events

• Subsidiary Sale Terminated

  NutriBand's Board of Directors approved the immediate termination of the agreement to sell Pocono Pharmaceuticals, Inc. to Earth Vision Bio Inc.

• Buyer Defaulted on Payments

  The termination was due to Earth Vision Bio Inc.'s failure to pay applicable late fees under the purchase agreement, with no payments received since January 21, 2026.

• Strategic Implications

  This event adds to recent concerns, including a substantial net loss and an increase in authorized preferred stock, and occurs while the stock trades near its 52-week low.

auto_awesomeAnalysis

The termination of the sale of Pocono Pharmaceuticals, Inc. to Earth Vision Bio Inc. is a significant setback for NutriBand. The buyer's failure to make required payments indicates potential financial or operational issues with the acquiring party, or challenges in the deal itself. This news comes as NutriBand is trading near its 52-week low and follows recent disclosures of a substantial net loss and an increase in authorized preferred stock, suggesting ongoing financial pressures. The company will now need to reassess its strategy for Pocono Pharmaceuticals and potentially seek new buyers or integrate it back into its operations, which could impact its capital structure and future financial performance.